Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists
- 15 March 2003
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 465 (3), 211-218
- https://doi.org/10.1016/s0014-2999(03)01482-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pharmacological characterisation of native somatostatin receptors in AtT‐20 mouse tumour corticotrophsBritish Journal of Pharmacology, 2003
- Drug Design at Peptide ReceptorsJournal of Molecular Neuroscience, 2002
- Small molecule somatostatin receptor subtype-2 antagonistsBioorganic & Medicinal Chemistry Letters, 2001
- Highly Potent Cyclic Disulfide Antagonists of SomatostatinJournal of Medicinal Chemistry, 1999
- A Linear Hexapeptide Somatostatin Antagonist Blocks Somatostatin ActivityIn Vitroand Influences Growth Hormone Release in RatsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,1998
- Potent Antagonists of Somatostatin: Synthesis and BiologyJournal of Medicinal Chemistry, 1998
- Molecular pharmacology of somatostatin receptorsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1994
- The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cellsMolecular Endocrinology, 1994
- Somatostatin Inhibits Vasoactive Intestinal Peptide-Stimulated Cyclic Adenosine Monophosphate Accumulation in GH Pituitary Cells*Endocrinology, 1983
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973